Evolus (EOLS) Amortization of Deferred Charges (2018 - 2026)
Evolus (EOLS) reported Amortization of Deferred Charges of $361000.0 for Q1 2026, up 19.93% on a YoY basis from $301000.0 in Q1 2025, and up 5.25% quarter-over-quarter from $343000.0 in Q4 2025.
Evolus (EOLS) Amortization of Deferred Charges (2018 - 2026) Analysis & Trends
Evolus has reported Amortization of Deferred Charges for 9 years, with the latest figure at $361000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges rose 19.93% year-over-year to $361000.0; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 15.2% YoY), and the FY2025 full-year result was $1.3 million, up 12.38% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $361000.0, up from $343000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $361000.0 in Q1 2026, with the low at $263000.0 in Q1 2022.
- Historically, Amortization of Deferred Charges has averaged $294058.8 across 5 years, with a median of $282000.0 in 2024.
- The largest YoY upside for Amortization of Deferred Charges was 188.31% in 2022 against a maximum downside of 58.0% in 2022.
- Evolus' Amortization of Deferred Charges stood at $281000.0 in 2022, then fell by 2.85% to $273000.0 in 2023, then advanced by 9.16% to $298000.0 in 2024, then gained by 15.1% to $343000.0 in 2025, then climbed by 5.25% to $361000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $361000.0 (Q1 2026), $343000.0 (Q4 2025), and $336000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 361,000.00 |
| Mar 31, 2026 | 361,000.00 |
| Dec 31, 2025 | 343,000.00 |
| Dec 31, 2025 | 343,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Jun 30, 2025 | 309,000.00 |
| Jun 30, 2025 | 309,000.00 |
| Mar 31, 2025 | 301,000.00 |
| Mar 31, 2025 | 301,000.00 |
| Dec 31, 2024 | 298,000.00 |
| Dec 31, 2024 | 298,000.00 |
| Sep 30, 2024 | 290,000.00 |
| Sep 30, 2024 | 290,000.00 |
| Jun 30, 2024 | 282,000.00 |
| Jun 30, 2024 | 282,000.00 |
| Mar 31, 2024 | 277,000.00 |
| Mar 31, 2024 | 277,000.00 |
| Dec 31, 2023 | 273,000.00 |
| Dec 31, 2023 | 273,000.00 |